CA Stock MarketDetailed Quotes

MSCL Satellos Bioscience Inc

Watchlist
  • 0.970
  • +0.070+7.78%
15min DelayMarket Closed Dec 13 16:00 ET
110.19MMarket Cap-3.88P/E (TTM)

About Satellos Bioscience Inc Company

Satellos Bioscience Inc is a regenerative medicine company a biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

Company Profile

SymbolMSCL
Company NameSatellos Bioscience Inc
Founded2012
MarketTSE
Employees16
Fiscal Year Ends12-31
Address200 Bay Street Suite 2800, Royal Bank Plaza, South Tower
CityToronto
CountryCAN
Zip CodeM5J 2J1
Phone+1 905 336-6128
Websitehttps://www.satellos.com

Company Executives

  • Name
  • Position
  • Salary
  • Frank Gleeson
  • President, Chief Executive Officer and Director
  • --
  • Dr. Michael Cross
  • Chief Business Officer
  • --
  • Elizabeth Willia C.A.,C.P.A.
  • Chief Financial Officer
  • --
  • Dr. Philip Lambert, PhD
  • Chief Scientific Officer
  • --
  • Dr. Michael Rudnicki, F.R.S.
  • Chief Discovery Officer
  • --
  • Courtney Wells
  • Senior Vice President, Clinical Development Operations
  • --
  • Geoff Mackay
  • Chairman of the Board
  • --
  • Franklin M. Berger, C.F.A.
  • Director
  • --
  • William Jarosz
  • Director
  • --
  • Brian Bloom
  • Director
  • --
  • Dr. William K. McVicar, PhD
  • Independent Director
  • --
  • Adam S. Mostafa
  • Independent Director
  • --
  • Dr. Rima Al-awar
  • Independent Director
  • --
  • Warren Whitehead
  • Head of Corporate Strategy
  • --
Heat List
CA
Overall
Symbol
Price
% Chg

No Data